Paracrine signaling via delivery of bioactive molecules

Paracrine signaling via delivery of bioactive molecules is not a single molecule or receptor, but rather a process of cell-to-cell communication in which a cell secretes signaling molecules—such as growth factors, cytokines, peptides, and hormones—that diffuse through the extracellular matrix to act on nearby target cells[3][1][2]. These signals usually elicit rapid, short-lived responses that are tightly regulated by rapid degradation or uptake of the signaling molecules, ensuring effects remain localized[2][4]. Paracrine factors bind to specific receptors on the surface of adjacent cells, initiating signaling cascades such as the MAPK/ERK, PI3K/AKT, or JAK/STAT pathways, resulting in diverse cellular outcomes like proliferation, differentiation, survival, tissue repair, inflammation, and more[1][3][6][8]. The spectrum of paracrine signals is broad and includes well-known families such as fibroblast growth factors (FGF), vascular endothelial growth factor (VEGF), cytokines (e.g., IL-1, TNF-alpha), nitric oxide, and neurotransmitters[1][6]. Paracrine signaling plays key roles in many physiological and disease processes—among them, cancer progression, diabetes (especially in pancreatic islet biology), inflammation, wound healing, cardiovascular disease, and regeneration[3][7][4][8]. While the receptors and molecular pathways activated by specific paracrine factors (e.g., FGF receptor, nitric oxide receptor guanylate cyclase) are clear therapeutic targets, paracrine signaling as a process, or “paracrine signaling via delivery of bioactive molecules,” is not itself a discrete drug target or receptor[3][6]. Therefore, it cannot be classified as a canonical molecule or therapeutic target; rather, it describes the mechanism by which a wide variety of distinct molecules exert their functions at the local cellular level[7][1].

Other names

Paracrine signalingParacrine signaling pathwayParacrine communicationParacrine mechanismParacrine factor delivery